Company: MDCXW
Filing Date: 2025-05-30
Form Type: 424B4
Source: 0001062993-25-010548
Chunk: 70

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-30
Form: 424B4
Chunk 70
---
 with GAAP; and

-on an adjusted basis to reflect the net proceeds from our sale of 2,260,000 Units in this offering at the offering price of $3.10 per Unit, after deducting the underwriting discounts and commissions and the estimated offering expenses.

This table should be read in conjunction with the "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Use of Proceeds" sections, as well as our audited financial statements, included elsewhere in this prospectus.

|                            |   | As of March 31, 2025 |   |   |             |   |
|:---------------------------|:--|---------------------:|:--|:--|------------:|:--|
|                            |   |               Actual |   |   |    Adjusted |   |
| Cash                       | $ |            3,982,430 |   | $ |  10,212,980 |   |
| Liabilities                |   |            3,510,312 |   |   |   3,510,312 |   |
| Shareholders' equity:      |   |                      |   |   |             |   |
| Share capital              |   |           32,908,702 |   |   |  39,139,252 |   |
| Additional paid-in capital |   |            3,245,163 |   |   |   3,245,163 |   |
| Deficit                    |   |          (34,006,311 | ) |   | (34,006,311 | ) |
| Total shareholders' equity |   |            2,147,554 |   |   |   8,378,104 |   |
| Total capitalization       | $ |            5,657,866 |   | $ |  11,888,416 |   |

<div align='center'>44

USE OF PROCEEDS</div>

We estimate that the net proceeds to us from this offering will be approximately $6.2 million, based on an offering price of $3.10 per Unit, after deducting placement agent fees of approximately $525,000 and estimated offering expenses payable by us of approximately $250,000.

In addition, we would receive up to an aggregate of approximately $7.0 million from the exercise of the warrants, assuming the exercise in full of all such warrants for cash.

We intend to use the net proceeds from this